Clinical & Diagnostic
CSL Vifor and Travere Therapeutics Secure Swissmedic Approval for FILSPARI in Treatment of IgA Nephropathy
CSL Vifor and Travere Therapeutics, announced that Swissmedic has granted temporary marketing authorization for FILSPARI for the treatment of adults w...
October 18, 2024 | News
Sunbird Bio Secures $14M in New Funding from Eli Lilly and EDBI to Advance Blood-Based Diagnostic Technology for Neurological Disorders
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to furth...
October 17, 2024 | News
TenNor Therapeutics Secures Over 300 Million RMB in Series E Funding to Advance Novel Antibiotics for Drug-Resistant Infections
TenNor Therapeutics, a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases, announced today the init...
October 17, 2024 | News
SONIRE Therapeutics Secures FDA Breakthrough Device Designation for Advanced HIFU Therapy in Pancreatic Cancer
SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (Hi...
October 17, 2024 | News
Endogenex Achieves Key Clinical Milestone with First Patient Enrolled in ReCET™ Study for Type 2 Diabetes Treatment
Achieving a Significant Clinical Milestone in Assessing the ReCET™ System as a Groundbreaking Treatment for Type 2 Diabetes Endogenex, Inc., a clini...
October 16, 2024 | News
South Korea's Neurophet and AriBio Join Forces to Develop Advanced Diagnostic Platform for Alzheimer's
Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease - Collabor...
October 16, 2024 | News
CanSinoBIO Secures Over $17 Million Grant to Propel Polio Vaccine Trials in Indonesia and Advance Global Eradication Efforts
CanSino Biologics has announced a milestone in its fight against polio. The company has received an additional financial boost, securing a grant exceeding ...
October 11, 2024 | News
Genentech's Itovebi™ Wins FDA Approval for HR-Positive Breast Cancer, Doubling Progression-Free Survival in PIK3CA-Mutated Cases
– Approval is based on Phase III INAVO120 results, showing the ItovebiTM (inavolisib)-based regimen more than doubled progression-free sur...
October 11, 2024 | News
ShiraTronics Raises $66M in Series B to Advance Innovative Neuromodulation Therapy for Chronic Migraine Patients
Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Atta...
October 10, 2024 | News
MediLink Therapeutics and Amgen Announce Global Clinical Collaboration to Evaluate Combination Therapy for Extensive-Stage Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, announced a global clinical trial collaboration and supply agreeme...
October 08, 2024 | News
Telix Pharmaceuticals Secures TGA Approval for Illuccix® to Select Patients for PSMA-Targeted Radionuclide Therapy
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved the us...
October 08, 2024 | News
Innovent Biologics and ASK Pharm Announce Strategic Partnership to Commercialize Limertinib for EGFR-Mutated Lung Cancer in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 08, 2024 | News
Medinol Celebrates First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent in Australia
Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by Drs Gerard S.G...
October 07, 2024 | News
Hetero and Gilead Sciences Partner to Expand Global Access to Lenacapavir for HIV Treatment and Prevention
Non-exclusive voluntary license agreement enables the manufacture and distribution of lenacapavir for HIV prevention and treatment of heavily treatment-exp...
October 03, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
